loader from loading.io

PT223 - Daniel Carcillo - Life After Sports

Psychedelics Today

Release Date: 12/22/2020

PT506 – Decolonization, Difficult Conversations, and the Challenge of Merging Spirituality and Science, with Philip Wolf show art PT506 – Decolonization, Difficult Conversations, and the Challenge of Merging Spirituality and Science, with Philip Wolf

Psychedelics Today

In this episode, Joe interviews Philip Wolf: writer, member of Rolling Stone's Culture Council, founder of Cultivating Spirits (the first company in the U.S. to offer legal culinary cannabis experiences), and founder of CashoM, an education company offering a certificate in cannabis stewardship. He discusses his recent Rolling Stone article about the need to divorce ourselves from the colonial mindset that pervades the psychedelic movement, and he talks about the difficult conversation that came about when he asked a very critical group of psychedelic leaders how they felt about the article,...

info_outline
PT505 – Bicycle day Reflections, Quantum Mechanics, and the Value in Studying Philosophy to Understand Psychedelic Experiences, with Lenny Gibson, Ph.D. show art PT505 – Bicycle day Reflections, Quantum Mechanics, and the Value in Studying Philosophy to Understand Psychedelic Experiences, with Lenny Gibson, Ph.D.

Psychedelics Today

In this episode, Joe and Kyle interview Lenny Gibson, Ph.D.: philosopher, Grof-certified Holotropic Breathwork® facilitator, 20-year professor of transpersonal psychology at Burlington College, and the reason Joe and Kyle met many years ago. He talks about his early LSD experiences and how his interest in the philosophy of Plato and Alfred North Whitehead provided a framework and language for understanding a new mystical world where time and space were abstractions. He believes that while culture sees the benefits of psychedelics in economic terms, the biggest takeaway from non-ordinary...

info_outline
PT504 – Rethinking Drug Education: From D.A.R.E. Scare Tactics to an Evidence-Based Approach, with Joey Lichter, Ph.D. show art PT504 – Rethinking Drug Education: From D.A.R.E. Scare Tactics to an Evidence-Based Approach, with Joey Lichter, Ph.D.

Psychedelics Today

In this episode, Joe interviews Joey Lichter, Ph.D.: professor in the Chemistry & Biochemistry department at Miami’s Florida International University, and one of the few professors in the U.S. teaching a course about psychedelics at the collegiate level. He talks about his path towards the course, the challenge of creating a curriculum that covers everything in a few months, and the importance of teaching young minds about psychedelics the right away; shifting drug education from the “Just say no!” D.A.R.E. model to a more balanced, honest, and evidence-based approach. He aims for...

info_outline
PT503 – Updates from MAPS: Current Initiatives, Psychedelic Science 2025, and Music as a Bridge, with Devon Phillips show art PT503 – Updates from MAPS: Current Initiatives, Psychedelic Science 2025, and Music as a Bridge, with Devon Phillips

Psychedelics Today

In this episode, Joe interviews Devon Phillips: community & partnerships officer for the Multidisciplinary Association for Psychedelic Studies (MAPS). Phillips works on strategies to tackle the questions: How do we responsibly mainstream psychedelics? And how do we get culture engaged? He's focusing on being the bridge to psychedelics outside of research, facilitating workshops and psychedelic coming-out stories at music festivals and conferences. He talks about harm reduction and drug checking at festivals, the concept of training big names to become trustworthy resources, the differences...

info_outline
PT502 – Preserving Psychedelic Legacies: Shulgin Farm and the Shulgin Archive Project, with Keeper Trout show art PT502 – Preserving Psychedelic Legacies: Shulgin Farm and the Shulgin Archive Project, with Keeper Trout

Psychedelics Today

In this episode, Joe interviews Keeper Trout: archivist, author, photographer, co-founder of the Cactus Conservation Institute, and creator of Trout’s Notes, a website compiling personal research and collected data to help ethnobotanical researchers. From an interest in cactus taxonomy, Sasha Shulgin urged Trout to go through his files, resulting in a friendship, and eventually, an 8-year project of digitizing all of these files into the ever-evolving Shulgin Archive. Trout discusses: His relationship with Sasha and The Shulgin Farm project, which aims to make the farm a community resource...

info_outline
PT501 – Women and Psychedelics, Microdosing, and the Challenges of Psychedelic Parenthood, with April Pride show art PT501 – Women and Psychedelics, Microdosing, and the Challenges of Psychedelic Parenthood, with April Pride

Psychedelics Today

In this episode, Alexa interviews April Pride: creative entrepreneur, veteran of the cannabis space, and now, founder of SetSet, an educational platform and podcast (picking up where The High Guide left off) for women curious about psychedelics. With Alexa about to embark on the journey of motherhood, she asks many of the questions parents working with psychedelics have to consider: How do you overcome the stigmas of being a psychedelic parent? How do you talk to your children about drugs? How do you know if a substance is ok to use during pregnancy? Pride discusses: Being dubbed “the weed...

info_outline
PT500 – Shulgin Farm and the Future of Psychedelic Drug Development, with Paul F. Daley, Ph.D. show art PT500 – Shulgin Farm and the Future of Psychedelic Drug Development, with Paul F. Daley, Ph.D.

Psychedelics Today

In this episode, Joe interviews Paul F. Daley, Ph.D., who worked with Sasha Shulgin in his lab for the last seven years of his life, helping him finish (and co-authoring) "The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds." He is now the co-founder, Chief Science Officer, and Director of Analytical Science at the Alexander Shulgin Research Institute (ASRI), focusing on the discovery and development of novel psychedelic compounds. While Sasha was passionate about self-experimentation, the Institute is aiming for the next step for these drugs: FDA approval.  ...

info_outline
PT499 – Osiris González Romero – Mesoamerican Psychedelics, Decolonization, and the Concept of an Ontological Turn show art PT499 – Osiris González Romero – Mesoamerican Psychedelics, Decolonization, and the Concept of an Ontological Turn

Psychedelics Today

In this episode, David interviews Osiris González Romero: philosopher and Postdoctoral researcher on cognitive freedom and psychedelic humanities at the University of Saskatchewan. Romero believes that our weakest point of research is our knowledge of Indigenous languages, and is focused on highlighting different cultural uses of psychedelics to better inform future drug policy. He’s currently studying more than 100 documents (including one over 400 years old) to establish an honest understanding of why peyote was ever banned. He discusses: Mesoamerican psychedelics and their relevance to...

info_outline
PT498 – Maria Mangini, Ph.D., FNP – Traversing the Psychedelic Landscape: From Esalen and Millbrook to the Future of Shulgin Farm show art PT498 – Maria Mangini, Ph.D., FNP – Traversing the Psychedelic Landscape: From Esalen and Millbrook to the Future of Shulgin Farm

Psychedelics Today

In this episode, Joe interviews Maria Mangini, Ph.D., FNP: researcher, educator, and midwife who has worked closely with many psychedelic innovators and was part of the original social network at Shulgin Farm – where this episode was recorded. She traces her journey from the influence of pioneers like the Wassons, Shulgins, and Grofs, and historic places like Esalen and Millbrook. She discusses: Her early experiences with the Grofs at Esalen and how she met the Shulgins Gregory Bateson guiding her to become a midwife The similarities between midwifery and psychedelic facilitation The unsung...

info_outline
PT497 – Wendy Tucker – Reflections from Shulgin Farm: Psychedelics, Legacy, and the Spirit of Discovery show art PT497 – Wendy Tucker – Reflections from Shulgin Farm: Psychedelics, Legacy, and the Spirit of Discovery

Psychedelics Today

In this episode, released on Ann Shulgin’s birthday, Joe interviews Wendy Tucker: daughter of Ann and stepdaughter to Alexander “Sasha” Shulgin. Recorded in Sasha’s old office, she recounts her formative years, giving an insider’s look into her Mother’s openness about psychedelics, working with Sasha in the lab, how the Shulgins made a perfect team, and watching a close-knit circle of self-experimenters start to form at Shulgin Farm – and keep coming back over the years. She talks about the energy infused into the property from the decades of research and gatherings, and how she...

info_outline
 
More Episodes

In this episode, Joe interviews "Car Bomb"- the 9-year NHL veteran, 2-time Stanley Cup winner (as a member of the Chicago Blackhawks), founder of The Chapter Five Foundation (an organization helping athletes transition into post-sports life), and advocate for the healing power of psilocybin, Daniel Carcillo.

Carcillo tells the story of his struggles and depression brought on from post-hockey life transition, 7 diagnosed concussions, and the death of his good friend and fellow player, Steve Montador, who struggled with similar issues before his sudden death in 2015. He talks about the stress of pro sports and the cult-like, team-first attitude in hockey, the hazing athletes experience coming up, the causes and effects of yelling coaches and a "be better" attitude, and how his post-hockey work and speaking out has ostracized him from the community while many people are reaching out to him for help behind the scenes. 

His first hero dose of psilocybin forever changed his life, but it wasn't just psilocybin- he's done a lot in the 5 years since that first ceremony, from neurofeedback, acupuncture, deprivation tanks, and using a gyrostim, to regularly microdosing, taking medicinal mushrooms like lion's mane and reishi, meditating, starting a CBD and supplements company, and growing huge crops of cannabis. He talks about how this has all helped improve his life and his relationships with his family, and what he hopes to do with his Chapter Five Foundation and beyond- researching more into what worked for him and developing a protocol/regiment to help people affected by concussions, post-concussive syndrome, TBIs, CTE, or just those struggling with what to do after sports.

Notable Quotes

“I’m an advocate for everything, for all tiers. I’m an advocate for the Decrim Nature [model] because it’s a lower-tier model to get people this medicine, and then I’m an advocate for the clinical model that people are pushing forward in Oregon, and I’m an advocate for these big pharma/biotech companies coming out and researching. ...You really have to make sure that we’re doing it the right way, and I think a lot of the companies out there are, so I think there’s such an opportunity at the ground floor right now to really get in, and if you have something that’s proven, that’s worked (like we do), then I really, really just feel so passionately about furthering that type of research, to again, get millions of people this type of treatment and this type of option.”

“It’s still kind of unbelievable when I begin to talk about it, kind of what I’ve set in motion, but I believe in it so much and I’m still really in awe of what this medicine has done for me. We have one life to live. How do I help the most people that I can?”

“I just had to adjust my whole perspective and thinking and how I spoke to myself, changing the negative motivation to positive. But it’s constant work, because I’m just so used to being yelled at and then [being negative towards myself]. It’s definitely one of the biggest shifts that I’ve had, and I had that shift- that was at 2 and a half months after that big ceremony. That’s where I knew- that’s what really convinced me, and I’ll never forget this: I was driving out to my plants and they were about, I don’t know, 3 feet tall, and we were about 2 and a half months in, and I was like, ‘Wow Dan, really good job.’ I had this voice say that and I was like, ‘What the hell was that? Where did that come from?’ I’ve never done that, ever, and I was like ‘Ohhh man, something happened. Something shifted.’”

Links

Danielcarcillo.com

Chapter5foundation.com

Madeplanthealth.com (his CBD and supplement company)

Twitter

Instagram

Psymposia.com: Chicago could become largest city to Decriminalize Entheogenic Plants

Yahoo Sports: NHL pins Steve Montador's fatal brain injuries on his ‘own lack of due care’

US Patent 6630507: The US Government's Cannabis Patent

Parkinsonsnewstoday.com: Silo Pharma Plans Phase 2B Trial Testing Low-dose Psychedelics in Parkinson’s

Gyrostim.com

Del Jolly’s Psychedelics Today episode (lots of concussion and TBI talk)


About Daniel Carcillo

Daniel Carcillo is a two time Stanley Cup Champion and played 9 seasons in the National Hockey League. Daniel experienced emotional, sexual and physical trauma within hockey's culture and battled mental health and addiction issues during and post career. When he retired in 2015, after sustaining 7 concussions and due to Post Concussion Syndrome, he founded Chapter 5 Foundation, a charitable organization that helps athletes transition into life after the game. Daniel struggled with PCS symptoms like light sensitivity, slurred speech, insomnia, headaches and head pressure, impulse control issues, anxiety, depression and suicidal thoughts and traditional treatments did not work. Daniel brought forth the Decriminalize Nature resolution to the city of Chicago, sits on the Decriminalize Nature National Advisory Board & the board of the Heroic Hearts Project, a registered 501(c)(3) non profit that connects military veterans struggling with mental trauma to ayahuasca therapy retreats. Daniel has recently founded Made Therapeutics, a life sciences company that is researching loading and maintenance doses of psilocybin to treat traumatic brain injury, Post Concussion Syndrome, migraines and TBI related anxiety, depression and PTSD. Daniel and Made Therapeutics will be working towards validating the first novel care option for TBI survivors through Health Canada (IMPD) and FDA (IND) clinical trials, with Pre-IMPD & Pre-IND meetings set to establish a pathway forward to fast track status for traumatic brain injury.

Support the show

Navigating Psychedelics